4.7 Article

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions

Johannes Schmucker et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Article Medicine, General & Internal

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

Louise Bowman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Cardiac & Cardiovascular Systems

Diabetes and antiplatelet therapy: from bench to bedside

Jose R. Rivas Rios et al.

CARDIOVASCULAR DIAGNOSIS AND THERAPY (2018)

Review Cardiac & Cardiovascular Systems

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk

Katherine Kearney et al.

CARDIOVASCULAR DIABETOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Association of MicroRNAs and YRNAs With Platelet Function

Dorothee Kaudewitz et al.

CIRCULATION RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Global Burden of Thrombosis Epidemiologic Aspects

Aaron M. Wendelboe et al.

CIRCULATION RESEARCH (2016)

Review Cardiac & Cardiovascular Systems

Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54

William A. E. Parker et al.

HEART (2016)

Article Cardiac & Cardiovascular Systems

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

Robert F. Storey et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Hematology

Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model

Mark R. Thomas et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)

Article Endocrinology & Metabolism

Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3

Katharina Hess et al.

DIABETOLOGIA (2014)

Article Hematology

The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease

Sos Neergaard-Petersen et al.

THROMBOSIS AND HAEMOSTASIS (2014)

Article Hematology

MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery

Manuel Mayr et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Circulating MicroRNAs as Novel Biomarkers for Platelet Activation

Peter Willeit et al.

CIRCULATION RESEARCH (2013)

Article Multidisciplinary Sciences

Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure

Sos Neergaard-Petersen et al.

PLOS ONE (2013)

Article Cardiac & Cardiovascular Systems

Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction

Anna Zampetaki et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

Review Biochemistry & Molecular Biology

Arterial thrombosis-insidious, unpredictable and deadly

Shaun P. Jackson

NATURE MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

Anna Zampetaki et al.

CIRCULATION RESEARCH (2010)

Article Cardiac & Cardiovascular Systems

Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

Laurent Bonello et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Hematology

VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA

A. A. Kondkar et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Article Hematology

Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System

R. A. Ajjan et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)

Article Immunology

Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans

Thea Morris et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Medicine, General & Internal

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial

Hisao Ogawa et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Hematology

Heritability of clot formation, morphology, and lysis - The EuroCLOT study

Angela M. Carter et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Medicine, General & Internal

Prasugrel versus clopidogrel in patients with acute coronary syndromes

Stephen D. Wiviott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Cardiac & Cardiovascular Systems

Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome

Robert F. Storey et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

Dominick J. Angiolillo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Article Peripheral Vascular Disease

Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm

Hamad S. Al-Barjas et al.

ANGIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Amplified benefit of Clopidogrel versus aspirin in patients with diabetes mellitus

DL Bhatt et al.

AMERICAN JOURNAL OF CARDIOLOGY (2002)